NCT05602103View on ClinicalTrials.gov

Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies

Not yet recruitingOBSERVATIONAL

Enrollment

10,000

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 6, 2025

Conditions

MalignanciesCardiovascular DiseasesChildren, Only

Interventions

DRUG

use of anticancer drugs in monotherapy or in combination therapy

Cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs will be identify and describe

All Listed Sponsors

lead

University Hospital, Caen

OTHER

NCT05602103 - Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies | Biotech Hunter | Biotech Hunter